cigna glp-1 program is ending employee coverage for weight-loss drugs like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Weight loss drugs' high costs
Description
Acknowledgements This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency
"I'll get messages or calls from patients asking, 'What do you think about microdosing?' That's how you should approach it shared decision-making with your provider." FAQs Is microdosing GLP-1 drugs FDA-approved
.svg?mw=810&hash=8DDE12336D7D7D5D6E4313F13293B26D)
Your digestive system is equipped with receptors that detect bitter compounds, not just in your mouth, but throughout your gut
Ready when you are 5 quick questions instant answer nothing stored The label always wins
